Recent Finacing
Recent Raise
Naveris develops and commercializes NavDx, a CLIA-certified blood-based diagnostic that uses proprietary DNA fragmentomics to detect HPV-associated cancers and provides testing services to U.S. cancer centers.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Naveris.
